Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of CBD Oil for Reducing the Negative Emotional Impact of COVID-19: A Randomized Placebo-Controlled Clinical Trial

NCT04603781 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT04603781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04603781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of CBD Oil for Reducing the Negative Emotional Impact of COVID-19: A Randomized Placebo-Controlled Clinical Trial
Lead sponsor
University of Texas at Austin
Phase
Phase 2/3
Overall status
Suspended
Start date
December 4, 2020
Completion date
December 31, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, anger, anxiety depression, sleep disturbance, stress reaction, substance abuse